106PDEGFR MUTATION DETECTION IN PLASMA OF LUNG TUMOR PATIENTS IN THE ABSENCE OF CONTRIBUTIVE TISSUE IS A RELEVANT ALTERNATIVE FOR PRESCRIPTION OF TYROSINE KINASE INHIBITORS IN A ROUTINE CLINICAL SETTING


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles